USD
+$0.00
(+0.00%
)At Close (As of Oct 17, 2025)
$142.01M
Market Cap
39.15
P/E Ratio
0.33
EPS
$21.98
52 Week High
$11.57
52 Week Low
CONSUMER CYCLICAL
Sector
Field | Value (USD) |
---|---|
Gross Profit | $445M |
Total Revenue | $602M |
Cost Of Revenue | $158M |
Costof Goods And Services Sold | $158M |
Operating Income | $2.9M |
Selling General And Administrative | $442M |
Research And Development | - |
Operating Expenses | $442M |
Investment Income Net | - |
Net Interest Income | $4.8M |
Interest Income | $4.8M |
Interest Expense | $4.8M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $13M |
Income Before Tax | $3.8M |
Income Tax Expense | $1.7M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $2.1M |
Comprehensive Income Net Of Tax | - |
Ebit | $2.9M |
Ebitda | $16M |
Net Income | $2.1M |
Field | Value (USD) |
---|---|
Total Assets | $284M |
Total Current Assets | $214M |
Cash And Cash Equivalents At Carrying Value | $91M |
Cash And Short Term Investments | $91M |
Inventory | $42M |
Current Net Receivables | - |
Total Non Current Assets | $70M |
Property Plant Equipment | $49M |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | $71M |
Other Current Assets | $9.6M |
Other Non Current Assets | - |
Total Liabilities | $74M |
Total Current Liabilities | $64M |
Current Accounts Payable | $23M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $6.2M |
Total Non Current Liabilities | $9.9M |
Capital Lease Obligations | $16M |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $16M |
Other Current Liabilities | $33M |
Other Non Current Liabilities | - |
Total Shareholder Equity | $210M |
Treasury Stock | - |
Retained Earnings | $177M |
Common Stock | $11K |
Common Stock Shares Outstanding | $11M |
Field | Value (USD) |
---|---|
Operating Cashflow | $24M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $17M |
Capital Expenditures | $7.5M |
Change In Receivables | - |
Change In Inventory | $12M |
Profit Loss | - |
Cashflow From Investment | -$27M |
Cashflow From Financing | -$1.5M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | $715K |
Dividend Payout Common Stock | $715K |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | -$836K |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | $2.1M |
Field | Value (USD) |
---|---|
Gross Profit | $445M |
Total Revenue | $602M |
Cost Of Revenue | $158M |
Costof Goods And Services Sold | $158M |
Operating Income | $2.9M |
Selling General And Administrative | $442M |
Research And Development | - |
Operating Expenses | $442M |
Investment Income Net | - |
Net Interest Income | $4.8M |
Interest Income | $4.8M |
Interest Expense | $4.8M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $13M |
Income Before Tax | $3.8M |
Income Tax Expense | $1.7M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $2.1M |
Comprehensive Income Net Of Tax | - |
Ebit | $2.9M |
Ebitda | $16M |
Net Income | $2.1M |
Field | Value |
---|---|
Ex Dividend Date | 2023-09-18 |
Declaration Date | 2023-09-07 |
Record Date | 2023-09-19 |
Payment Date | 2023-11-07 |
Amount | 1.65 |
Sector: CONSUMER CYCLICAL
Industry: PERSONAL SERVICES
Medifast, Inc. is a leading company in the health and nutrition industry, specializing in innovative weight loss and management products complemented by a holistic approach to healthy living. Based in Baltimore, Maryland, Medifast leverages a direct-to-consumer business model to cultivate strong customer relationships and enhance brand loyalty, particularly within the U.S. and Asia-Pacific regions. With a commitment to science-backed nutritional solutions, the company is strategically positioned to tap into the escalating global demand for effective health and wellness options, presenting substantial growth opportunities in a rapidly evolving market focused on health consciousness.